Quick Answer: RxSpan MD is a telehealth platform, not a drug, so this splits in two: the platform's job is connecting you to licensed care, and the medications it offers belong to a class with substantial published evidence behind the FDA-approved finished products
Clinical trials demonstrated that semaglutide reduced body weight by 15% or more in non-diabetic patients, establishing scientific rationale for broader application
The irony being that the purpose of GLP-1 drugs is to reduce cardiovascular disease risk
Weekly Habit Mastery Consistent weekly sessions provide the accountability needed to turn science into second nature for habits that stick
This prevents over-ordering and reduces waste
Timing considerations with GLP-1 medications: GLP-1 receptor agonists are typically administered once weekly (semaglutide [Ozempic, Wegovy], dulaglutide [Trulicity]) or once daily (liraglutide [Victoza, Saxenda]), with specific timing recommendations